Articles: palliative-care.
-
Int. J. Radiat. Oncol. Biol. Phys. · Nov 2000
Comparative StudyThe cost-effectiveness and cost-utility of high-dose palliative radiotherapy for advanced non-small-cell lung cancer.
To compute cost-effectiveness/cost-utility (CE/CU) ratios, from the treatment clinic and societal perspectives, for high-dose palliative radiotherapy treatment (RT) for advanced non-small-cell lung cancer (NSCLC) against best supportive care (BSC) as comparator, and thereby demonstrate a method for computing CE/CU ratios when randomized clinical trial (RCT) data cannot be generated. ⋯ The cost effectiveness and cost utility of high-dose palliative RT for advanced NSCLC compares favorably with the cost effectiveness of other forms of treatment for NSCLC, of treatments of other forms of cancer, and of many other commonly used medical interventions; and lies within the US $50, 000/QALY benchmark often cited for cost-effective care.
-
The drug hyoscine has several indications for symptom control for patients with end-stage disease. The transdermal preparation, Scopoderm, is most widely used to control excess salivary secretions but it can also have a role in the management of terminal secretions and in the control of nausea.
-
Oncology nursing forum · Nov 2000
Comparative StudyHospice and hospital oncology unit nurses: a comparative survey of knowledge and attitudes about cancer pain.
To identify knowledge strengths and weaknesses and misperceptions about cancer pain management between two groups of registered nurses in different settings. ⋯ Further research is needed regarding nurses' pain management behavior and outcomes of pain management education in various settings.